[{"address1": "301 Binney Street", "address2": "3rd Floor", "city": "Cambridge", "state": "MA", "zip": "02142", "country": "United States", "phone": "857 259 3860", "website": "https://www.scholarrock.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Its transforming growth factor beta (TGF\u00df) superfamily biology, its novel understanding of the molecular mechanisms of growth factor activation enabled us to develop a proprietary platform for development of monoclonal antibodies that locally and selectively target the precursor. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies. It is developing a pipeline of product candidates to deliver novel therapies to treat a range of serious diseases, including neuromuscular disorders, cardiometabolic disorders, cancer, fibrosis, and iron-restricted anemia. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts.", "fullTimeEmployees": 128, "companyOfficers": [{"maxAge": 1, "name": "Mr. David L. Hallal", "age": 58, "title": "CEO & Chairman of the Board", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 175732, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mo  Qatanani Ph.D.", "age": 50, "title": "Chief Scientific Officer", "yearBorn": 1974, "fiscalYear": 2024, "totalPay": 704681, "exercisedValue": 0, "unexercisedValue": 3032789}, {"maxAge": 1, "name": "Dr. Akshay K. Vaishnaw M.D., Ph.D.", "age": 61, "title": "President of R&D, Member of Scientific Advisory Board and Director", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 56140, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jing L. Marantz M.B.A., M.D., Ph.D.", "age": 59, "title": "Chief Medical Officer", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 755185, "exercisedValue": 0, "unexercisedValue": 673489}, {"maxAge": 1, "name": "Mr. Vikas  Sinha C.A., CPA, M.B.A.", "age": 61, "title": "Chief Financial Officer", "yearBorn": 1963, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert Keith Woods", "age": 56, "title": "Chief Operating Officer", "yearBorn": 1968, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Erin  Moore CPA", "age": 49, "title": "Interim Principal Financial & Accounting Officer", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Rushmie  Nofsinger", "title": "Vice President of Corporate Affairs & Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Junlin  Ho J.D.", "age": 45, "title": "General Counsel & Corporate Secretary", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 563729, "exercisedValue": 0, "unexercisedValue": 112564}, {"maxAge": 1, "name": "Ms. Caryn  Parlavecchio", "age": 52, "title": "Chief Human Resources Officer", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 9, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1748736000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 34.25, "open": 34.7, "dayLow": 33.78, "dayHigh": 35.74, "regularMarketPreviousClose": 34.25, "regularMarketOpen": 34.7, "regularMarketDayLow": 33.78, "regularMarketDayHigh": 35.74, "payoutRatio": 0.0, "beta": 0.297, "forwardPE": -15.920929, "volume": 1684840, "regularMarketVolume": 1684840, "averageVolume": 1290785, "averageVolume10days": 1310900, "averageDailyVolume10Day": 1310900, "bid": 25.51, "ask": 43.35, "bidSize": 2, "askSize": 2, "marketCap": 3249987840, "fiftyTwoWeekLow": 6.76, "fiftyTwoWeekHigh": 46.98, "fiftyDayAverage": 30.687, "twoHundredDayAverage": 30.413025, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 2948754688, "profitMargins": 0.0, "floatShares": 79237768, "sharesOutstanding": 94945600, "sharesShort": 15211664, "sharesShortPriorMonth": 16971737, "sharesShortPreviousMonthDate": 1744675200, "dateShortInterest": 1747267200, "sharesPercentSharesOut": 0.1602, "heldPercentInsiders": 0.04354, "heldPercentInstitutions": 1.18732, "shortRatio": 12.26, "shortPercentOfFloat": 0.2833, "impliedSharesOutstanding": 95001000, "bookValue": 3.292, "priceToBook": 10.397934, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -264164000, "trailingEps": -2.55, "forwardEps": -2.15, "enterpriseToEbitda": -10.962, "52WeekChange": 2.554517, "SandP52WeekChange": 0.119305134, "quoteType": "EQUITY", "currentPrice": 34.23, "targetHighPrice": 57.0, "targetLowPrice": 45.0, "targetMeanPrice": 49.66667, "targetMedianPrice": 50.0, "recommendationMean": 1.4, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 9, "totalCash": 364375008, "totalCashPerShare": 3.838, "ebitda": -268992992, "totalDebt": 63143000, "quickRatio": 9.749, "currentRatio": 10.253, "debtToEquity": 20.217, "returnOnAssets": -0.50146, "returnOnEquity": -1.0671, "grossProfits": -190134000, "freeCashflow": -134323008, "operatingCashflow": -229839008, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SRRK", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1749251823, "regularMarketTime": 1749240000, "exchange": "NMS", "messageBoardId": "finmb_548810128", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -0.0583955, "regularMarketPrice": 34.23, "marketState": "CLOSED", "earningsTimestamp": 1747220400, "earningsTimestampStart": 1754483400, "earningsTimestampEnd": 1754915400, "earningsCallTimestampStart": 1747224900, "earningsCallTimestampEnd": 1747224900, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.55, "epsForward": -2.15, "epsCurrentYear": -2.75122, "priceEpsCurrentYear": -12.441753, "fiftyDayAverageChange": 3.5429993, "fiftyDayAverageChangePercent": 0.11545603, "twoHundredDayAverageChange": 3.8169746, "twoHundredDayAverageChangePercent": 0.1255046, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1527255000000, "shortName": "Scholar Rock Holding Corporatio", "longName": "Scholar Rock Holding Corporation", "postMarketChangePercent": 7.71253, "postMarketPrice": 36.87, "postMarketChange": 2.64, "regularMarketChange": -0.0200005, "regularMarketDayRange": "33.78 - 35.74", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1290785, "fiftyTwoWeekLowChange": 27.47, "fiftyTwoWeekLowChangePercent": 4.063609, "fiftyTwoWeekRange": "6.76 - 46.98", "fiftyTwoWeekHighChange": -12.75, "fiftyTwoWeekHighChangePercent": -0.27139208, "fiftyTwoWeekChangePercent": 255.4517, "displayName": "Scholar Rock Holding", "trailingPegRatio": null, "__fetch_time": "2025-06-07"}]